Bavarian Nordic A/S (BVNKF) Financials

BVNKF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.2 billion 217.1 million
Dec. 31, 2025 2.3 billion 326.9 million
Sept. 30, 2025 2.4 billion 314.5 million
June 30, 2025 2.2 billion 293.4 million

BVNKF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -120.4 million 4.3 million
Dec. 31, 2025 69.9 million 2.8 million
Sept. 30, 2025 196.0 million 2.8 million
June 30, 2025 73.8 million 3.1 million

BVNKF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.6 million
Dec. 31, 2025 -46.9 million
Sept. 30, 2025 171.8 million
June 30, 2025 57.3 million

BVNKF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 352.0 million 1.6 million 12.8 million
Dec. 31, 2025 522.8 million 1.7 million 11.7 million
Sept. 30, 2025 468.2 million 1.8 million 18.9 million
June 30, 2025 262.7 million 1.9 million 19.3 million

BVNKF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 11.8 million
Dec. 31, 2025 12.3 million
Sept. 30, 2025 12.5 million
June 30, 2025 12.7 million

BVNKF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.9 million 26.9 million 47.0 million -
Dec. 31, 2025 15.5 million 28.5 million 56.5 million -
Sept. 30, 2025 7.4 million 20.9 million 65.3 million 42.2 million
June 30, 2025 126.9 million 46.3 million 39.4 million 18.0 million

BVNKF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 162.6 million 89.6 million
Dec. 31, 2025 221.6 million 139.5 million
Sept. 30, 2025 282.2 million 141.8 million
June 30, 2025 260.9 million 116.6 million

BVNKF

Price: $27.82

52 week price:
26.08
37.60

Earnings Per Share: 2.36 USD

P/E Ratio: 12.89

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.1 billion

Links: